Calidi Biotherapeutics is a clinical-stage biotechnology company developing immunotherapies for cancer.
Calidi Biotherapeutics has raised $1.2M in total funding. The most recent round was Post-IPO Equity. The last funding was announced in September 2026.
Calidi Biotherapeutics's investors include California Institute for Regenerative Medicine, Jackson Investment Group, Greentable Co., Ltd., Calidi Cure.
Calidi Biotherapeutics is headquartered in San Diego, United States.
Calidi Biotherapeutics is a clinical-stage biotechnology company developing immunotherapies for cancer.
Calidi Biotherapeutics is at the Post-IPO Equity stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Calidi Biotherapeutics — Funding & Investors." VCBacked, September 17, 2026, https://www.vcbacked.co/company/calidi-biotherapeutics. Accessed November 12, 2026.
VCBacked. (2026). Calidi Biotherapeutics — Funding & Investors. Retrieved November 12, 2026, from https://www.vcbacked.co/company/calidi-biotherapeutics
{{cite web |title=Calidi Biotherapeutics — Funding & Investors |url=https://www.vcbacked.co/company/calidi-biotherapeutics |website=VCBacked |access-date=November 12, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated
Work at Calidi Biotherapeutics? Request a listing update